NCT06343220Completed
Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research
Source: ClinicalTrials.gov · Last updated 23 Dec 2025
Brief summary (registry, in English)
The Project AWARE 2.0 Survey is intended to gain knowledge about the feelings, attitudes, and beliefs of HD family members, care partners and others affected by HD towards the way drug trials and observational studies are communicated and conducted.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 131 (actual)
- First submitted
- 26 Mar 2024
- Start date
- 10 Apr 2024
- Primary completion date
- 22 Dec 2025
- Lead sponsor
- Huntington Study Group
- Diseases
- Huntington's disease
- NCT number
- NCT06343220
What you commit to
- Study type: Observational
- Participants enrolled: 131
- From 10 Apr 2024 to the primary completion date, 22 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Participants must either have HD or be at risk for having HD
- Participants must be 18 years of age or older
- Participants must live in the United States
- Inclusion of participants will not be based on race, gender, or ethnicity.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Huntington Study Group Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.